Nucleostemin (NS) is highly expressed in normal stem cells and tumors and is upregulated by estradiol in MCF7 breast cancer cells. To investigate the role of NS in mammary tumorigenesis, we established first that NS is expressed at higher levels in the basal cell type than in the luminal cell type in mouse mammary tumors and human breast cancer cells. NS expression was also increased during progression of mammary tumors in MMTV-Wnt1 and MMTV-PyMT transgenic mice and by the tumor sphere culture. To determine the function of NS-enriched tumor cells, we generated a bacterial artificial chromosome transgenic mouse line expressing green fluorescent protein (GFP) from the NS promoter and bred it to MMTV-Wnt1 mice, so that NS-expressing cells can be prospectively isolated based on their GFP levels. Notably, NS-enriched mammary tumor cells exhibited stronger in vitro and in vivo tumorigenic activities and expressed higher levels of K5, CD133, Oct4, telomerase reverse transcriptase, and C-X-C chemokine ligand 12 compared with NS-deficient mammary tumor cells. Furthermore, knockdown of NS dramatically reduced the sphere-forming activity of MDA-MB-231 and MCF7 human breast cancer cells. Our findings establish the tumor-initiating and molecular features of NS-enriched mammary tumor cells, suggesting that NS may offer a valuable therapeutic target.
Introduction
The existence of stemlike cells in cancer, better known as cancer stem cells (CSC) or tumor-initiating cells (TIC), was initially observed in acute myeloid leukemia (1, 2) and later found in solid tumors of the breast (3), brain (4) , and other tissues (5) (6) (7) (8) (9) . They are thought to be responsible for the recurrence, metastasis, and drug resistance of high-grade tumors (10) . The most commonly used markers for fluorescenceactivated cell sorting (FACS)-based enrichment of human mammary CSC (mCSC) are CD44 + CD24 −/low Lin − (3, 11, 12 (16, 17) , CD61 (18) , Oct4 (19) , CD133 (20) , Sca-1 (21, 22) , and ESA (23) . Most of the sorting schemes require multiparameter FACS, yield rather heterogeneous cell populations, and are unclear in their biological meaning.
Some of the markers, such as Sca-1 and CD24, have also been used as negative selectors for normal mouse mammary stem cells or human mCSC (3, 13, 14) . Enrichment of mCSC can also be based on their aldehyde dehydrogenase activity (24) . Nucleostemin (NS) was first isolated as a gene upregulated in MCF7 cells upon 17β-estradiol treatment (25) and later shown to function in maintaining the continuous proliferation of neural stem cells and cancer cells (26) . Since then, high levels of NS expression have been reported in ES cells, mesenchymal stem cells, germline stem cells, and human cancers (26) (27) (28) (29) . Together, these findings suggest a potential link between NS and mCSC. To investigate this possibility, we chose the MMTV-wnt-1 mice as our mammary tumor model (30) . The relevance of MMTVwnt-1 mammary tumors to human breast cancers is supported by frequent deregulations or mutations of the genes involved in the canonical Wnt signaling pathway (31) , particularly in the basal-like breast cancers (31) (32) (33) (34) (35) . Several Wnts are found overexpressed in human breast cancer tissues and cell lines (32) and necessary for their survival (31, (36) (37) (38) . Finally, the MMTV-wnt-1 mammary tumor exhibits mixed cell lineages of basal and luminal cells (39) (40) (41) , which resembles the broad spectrum of heterogeneity in human breast cancer samples and suggests perturbation at the mCSC/progenitor cell level (39, 40) . Here, we report that NS expression correlates with the basal subtype of mammary tumor cells, and that mammary tumor cells expressing higher levels of NS harbor stronger in vitro and in vivo tumorigenic activities. We also establish that NS is functionally required for the sphere-forming activity of human breast cancer cells.
Materials and Methods

Animal care
All animals were housed in the Program for Animal Resources of the Texas A&M Health Science Center and handled in accordance with the principles and procedure of the Guide for the Care and Use of Laboratory Animals.
Immunofluorescence and Western blot antibodies
Ab2438 was raised in chickens (Aves Labs) against mouse NS. Ab3404 was also raised in chickens against mouse GNL3L. Other primary antibodies include anti-K5 (Covance), K8 (TROMA-I, DSHB), K19 (TROMA-III, DSHB), proliferative cell nuclear antigen (PCNA; PC10, DSHB), K6 (Covance), and α-smooth muscle actin (SMA; Sigma). The antibody specificities were confirmed by staining parallel sections or blots of antigen-negative tissues.
Mammary tumor sphere and semisolid cultures
Mammary tumors were harvested from MMTV-wnt-1/ FVB/NJ female transgenic mice (Jackson Laboratory). Tumor tissues were minced and digested with collagenase and hyaluronidase. After filtering through 40-μm Nylon mesh, dissociated cells were cultured in DMEM/F12 medium, supplemented with apo-transferrin, selenium, insulin, fibroblast growth factor-2 (FGF2; 10 ng/mL), and epidermal growth factor (EGF; 20 ng/mL) in the attached, suspension, or semisolid culture. Fresh FGF2 and EGF were added daily, and medium was changed on a 3-day schedule. MDA-MB231 and MCF7 cells were maintained in DMEM-10% fetal bovine serum. For sphere culture, dissociated cells were plated in Corning ultralow attachment plates and incubated at 37°C under constant shaking. For semisolid cultures, 200 μL of 0.6% low-melting-point agar in experimental media was plated at the bottom of a 24-well plate. Single cells were resuspended in 0.3% agar in experimental media. Cell/agar mixtures of 5,000, 2,500, and 1,250 cells were plated in each well. Fresh media were changed every 3 days on top; colony formation was monitored daily and counted on day 12.
Flow cytometry
Dissociated cells were removed of lineage marker (CD5 + , CD45R + , CD11b + , Ly-6G/C + , 7-4, and Ter-119 + ) positive cells by magnetic bead sorting (Miltenyl Biotec). Lin -cells were resuspended at a concentration of 1 × 10 6 cells in 100 μL and labeled with biotinylated anti-CD24 antibody (clone M1/69), PE-conjugated antiCD29 antibody (clone HMb1-1), and APC-conjugated streptavidin (eBioscience). Cell sortings were done by MoFlo (Beckman Coulter Corporation) equipped with three lasers (water-cooled UV, aircooled argon, and an air-cooled HeNe). Dead cells, debris, and doublets were removed by forward and side scatter gating. The remaining live cell populations were then gated based on the signal intensities of positive and negative control samples. For green fluorescent protein (GFP) sorting, the GFP + cells were further divided into three equal parts (GFP low , GFP med , and GFP high ).
In vivo tumorigenic assay GFP-sorted tumor cells were resuspended in 100 μL of DMEM/F-12 medium at different cell densities and injected into the fourth inguinal mammary glands of 6-to 8-week-old athymic nude female mice. Tumor formation and growth were monitored twice a week, and the final count was tallied at 7 weeks after the injection. The TIC percentages in the injected cells were calculated by the L-Calc software. Tumor volume was calculated by the formula: 0.52 × (width) 2 × length.
siRNA knockdown of NS One day after plating, cells were incubated with siRNA duplexes (100 nmol/L, Dharmacon Research) complexed with oligofectamine (Invitrogen) for 24 hours and then cultured in fresh medium for 48 hours. The sense siRNA sequences are 5′-GAA CUA AAA CAG CAG CAG AdTdT-3′ (siNS) and 5′-UGA CGA UCA GAA UGC GAC UdTdT-3′ (siScr).
Results
NS is expressed at a higher level in the basal cell type than in the luminal cell type of mammary tumors First, the expression of NS in normal mammary glands was analyzed by immunofluorescence. The NS signals were detected in the nucleolus of both keratin 5-positive (K5 + ) basal and K8 + luminal cells, but the strongest signals were found in scattered basal cells (arrows; Fig. 1A ). To determine the expression cell type(s) of NS in mammary tumors, MMTV-wnt-1 tumors were dissociated and triple stained for NS, K8,andK5 (Fig.1B2 )orNS,K5,andSMA (Fig.1B3) (Fig. 1C) . Here, we did not observe a difference in the NS transcript levels between the K5 + and SMA + groups as we did by immunofluorescence, which compares the signal intensity of NS proteins in the nucleolus. In support of the higher level of NS in basal than in luminal tumor cells, Western blots showed that the MMTV-wnt-1 tumors express higher levels of NS, K5, and SMA and a lower level of K19 than MMTV-PyMT (polyomavirus middle T antigen) tumors, which contain predominantly luminal cells (Fig. 1D ). In human cancer cell lines, the level of NS protein is also significantly higher in the MDA-MB231 basal breast cancer cells than in the MCF7 luminal breast cancer cells (Fig. 1E ). Thus, + subgroup. Bars, mean ± SEM (n = 6); **, P < 0.001; ***, P < 0.0001. D, Western blot comparison between MMTV-wnt-1 and MMTV-PyMT mammary tumors (two samples each) showed that NS expression correlates with the levels of K5 and SMA and is opposite to that of K8. E, the basal-type human cancer cells (MDA-MB231) express more NS than the luminal-type human cancer cells (MCF7). Tub, α-tubulin. 
NS expression correlates with MMTV-wnt-1 and MMTV-PyMT tumor progression
To determine the relationship between NS expression and mammary tumor progression, Western blotting was done on samples collected from normal mammary glands and the small (≤0.5 cm in diameter) and large (≥1.0 cm in diameter) MMTV-wnt-1 tumors (Fig. 2A) . The luminal (K19 + ) and basal (K5 + ) cell contents increase in the cancerous tissues compared with the normal glands, but differ very little between the small and large tumors. NS is undetectable in normal glands with the amount of protein loaded, but increases dramatically in the large tumors compared with the small tumors, suggesting that its expression is upregulated as tumors advance. This progression-associated increase of NS expression is relatively specific and not seen in GNL3L. It is also not a by-product of increased cell proliferation, as determined by the amount of PCNA. To identify the tumor cell type that expresses NS in the large tumors, double-labeled immunofluorescence (IF) was done for NS and either K8 or K5. The results showed that the NS signals are more intense in the K5 + cells than in the K8 + cells (Fig. 2B) . Compared with the normal mammary epithelium, a slight increase of NS expression was noted in the hyperplasic mammary epithelium of MMTV-wnt-1 mice before the emergence of tumor foci ( Supplementary Fig. S1 ). To strengthen the correlation between NS expression and tumor progression, the NS levels were quantified during tumor progression in the MMTVPyMT transgenic model. MMTV-PyMT mice form mammary hyperplasia, adenoma/mammary intra-epithelial neoplasia (MIN), and carcinoma at 4, 8, and 12 weeks of age, respectively, which mimics human breast cancer progression (42) . Western blotting showed that the epithelial components are similar in the adenoma/MIN isolated from the 8-week-old mice and the carcinoma isolated from the 12-week-old mice (0.7 vs.1.0 for K5 and 0.8 vs.1.0 for K19; Fig. 2C ). More importantly, the NS protein level is 10-fold higher in the carcinoma than in the adenoma/MIN. IF showed that this stage-dependent increase of NS expression in MMTV-PyMT mice correlates with an increased number of cells with strong NS signals and weak K8 signals (Fig. 2D) . These data show a positive correlation between NS expression and tumor progression in two different mouse mammary tumor models.
NS-expressing cells are enriched by tumor sphere culture
Increased NS expression during tumor progression suggests that NS-enriched tumor cells may be more tumorigenic and possess more mCSC properties than NS-deficient cells. To investigate this possibility, tumor spheres were grown from dissociated MMTV-wnt-1 mammary tumor cells, passaged every 8 to 13 days, and collected from passage 1 (P1) to P3 (Fig. 3A) . Western blots showed that P1 tumor spheres expressed significantly higher levels of NS, K5, and K6 (a putative marker of mammary progenitor cells (14, 39) ) than the P0 primary tumor cells (Fig. 3B) . The levels of NS and K5 also increase slightly from the P1 spheres to the P2 spheres. This pattern of increase in NS expression matches the increase of sphere-forming efficiency from the P0 to P1 culture (P < 0.01, t test, n = 3; Fig. 3C ). By contrast, K19, SMA, and PCNA display the opposite expression pattern. These findings suggest that NS-enriched cells may be better at forming spheres in vitro and initiating tumors in vivo.
Tumor cells expressing more NS display higher in vitro sphere-forming activities and in vivo tumorigenicity Next, we tested whether tumor cells with higher NS expression levels may show stronger tumorigenic activities. To purify live NS-expressing cells, we created a bacterial artificial chromosome (BAC)-based transgenic model, in which the expression of GFP is instructed by the NS promoter. The transgenic construct was built from a BAC clone (RP23-102M6), where GFP was fused in-frame to the start codon of NS, thus placing the expression of GFP under the control of the 224-kb genomic sequence surrounding the NS locus (Fig. 4A) . Two transgenic lines were created and verified for their transgene integrity and expression (43) , one of which, GFP NS (#14), was bred into the MMTV-wnt-1 mice. Mammary tumors were harvested from the GFP NS × MMTV-wnt-1 mice, dissociated, and FACS-sorted based on their GFP expression levels into the NS-negative (NS neg ), low (NS lo ), medium (NS med ), and high (NS hi ) groups (Fig. 4B) . qRT-PCR assays verified the relative NS expression levels in these four groups of cells and showed that the NS hi group expresses the highest level of CD61, Thy1, and CD24 (Fig. 4C ). This expression profile fits the published results, which used the CD61 + or Thy1 + CD24 + sorting paradigm to isolate TIC from MMTV-wnt-1 tumors (15, 18) .
To compare their tumorigenic activities in vitro, the GFPsorted cells were plated in suspension culture (1 × 10 6 cells per well). Only the NS med and NS hi cells exhibit strong activities to form spheres with size larger than 50 μm in diameter (P < 0.05, t test, n = 9; Fig. 4D ). The numbers of small-sized spheres (≤50 μm), which represent the nonself-renewing progenitor cells, are comparable between the NS lo , NS med , and NS hi groups. The NS neg cells did not form even small-sized spheres, suggesting that they lack any progenitor functions. The GFP-sorted cells were also measured for their abilities to form colonies in semisolid medium. In support of the tumor sphere findings, NS med and NS hi cells formed three times more colonies (>50 μm in diameter) in the semisolid culture than NS lo cells did (P < 0.001, t test, n = 9), and no colony was formed in the NS neg group (Fig. 4E) . To determine the in vivo tumorigenic potential of NSexpressing cells, these GFP-sorted mammary tumor cells were transplanted into the fourth inguinal mammary fat pads A, tumor spheres were cultured from MMTV-wnt-1 mammary tumors. Phase-contrast images were taken on the 10th day of each passage. Bar, 50 μm. B, primary tumor spheres (P1) express significantly more NS, K5, and K6 and less K19, SMA, and PCNA compared with the primary tumor (P0). The increase of NS and K5 levels moderates after P1. C, the expression patterns of NS and K5 match the significant increase of sphere-forming efficiency from the P0 to P1 culture (P < 0.01, t test, n = 3 Fig. 5A and Supplementary  Fig. S2 ). Once tumors formed at the transplanted sites, those derived from NS hi cells grew at the same rate [volume double time (T 2 ) = 5.2 days] as the ones derived from NS med cells (T 2 = 4.9 days) and NS lo cells (T 2 = 6.6 days; Fig. 5B ).
The NS expression shows high degrees of correlation with that of K5, CD133, Oct4, telomerase reverse transcriptase, and C-X-C chemokine ligand 12
To distinguish the molecular identities of NS hi versus NS lo cells, qRT-PCR assays were done to determine their expressions of genes related to stem cells [e.g., CD133, Oct4, telomerase reverse transcriptase (TERT), Sca-1, and Bmi-1] or the malignant progression of breast cancers [e.g., C-X-C chemokine ligand 12 (CXCL12), C-X-C chemokine receptor 4 (CXCR4), and matrix metallopeptidase 2 and 9]. Because none of these genes is specifically expressed in only one cell group, we measured their expression profiles across all four groups of GFP-sorted mammary tumor cells and calculated their correlation coefficiencies (r) with NS. Based on the calculation that the significance of correlation coefficient ≥0.95 equals P ≤ 0.05 (two-tailed, n = 4), we conclude that the expression of NS shares significant correlation with that of K5, CXCL12, CD133, Oct4, and TERT (Fig. 5C ).
NS depletion blocks the sphere-forming activity of MDA-MB231 and MCF7 human breast cancer cells The high tumorigenic activity of NS hi mammary tumor cells suggests that NS may be functionally important for mammary tumor progression. To examine this possibility, we measured the effect of NS knockdown on the tumor sphere-forming activity of MDA-MB231 and MCF7 cells. NS knockdown was introduced by oligofectamine-mediated ) groups; right, the GFP-negative control plot. C, qRT-PCR assays confirmed the relative expression levels of NS in these four sorted groups and showed that NS hi cells express significantly higher levels of CD61 and Thy1 and a moderately increased CD24 compared with the other groups. D, the NS med and NS hi groups display significantly higher sphere-forming activities than the NS neg and NS lo groups. Y-axis marks the number of tumor spheres generated from 1 × 10 6 plated cells. Black bars represent spheres >50 μm in diameter. Gray bars show spheres of 20 to 50 μm in diameter. E, the four GFP-sorted cell groups were cultured in semisolid medium. The number of isolated colonies (>50 μm) in the NS hi and NS med groups are three times higher than that in the NS lo group (n = 9). Bars, 100 μm; bar graphs, means ± SEM.
transfection of a NS-specific siRNA duplex (siNS). Control samples were treated with a siRNA duplex targeting a scrambled sequence (siScr). Two days after the knockdown, these cells were plated in suspension culture and allowed to grow for 12 days. The siNS treatment led to more than 90% knockdown of the NS protein in MDA-MB231 cells and 75% knockdown of NS proteins in MCF7 cells (Fig. 6A) . It also caused a significant decrease of K5 in MDA-MB231 cells. Importantly, NS knockdown dramatically reduced the ability of MDA-MB231 to form tumor spheres-only 2.8 spheres were detected from 10 4 siNS-treated cells plated, whereas 180 spheres were found in the siScr-treated group (P < 0.001, t test, n = 18; Fig. 6B and C) . Although the luminal MCF7 cells expressed only low levels of NS and formed much fewer spheres compared with MDA-MB231 cells, NS depletion still significantly decreased their sphere-forming activity (P < 0.001, t test, n = 12), suggesting that NS may be important for the tumorinitiating potential of a wide range of breast cancers.
Discussion
Mammary TIC express high levels of NS Several pieces of evidence indicate that TICs express more NS than non-TICs in mammary tumors. First, the expression level of NS is higher in the basal subtype than in the luminal subtype of human and mouse mammary tumor cells and correlates with the progression of mammary tumors in MMTVwnt-1 and MMTV-PyMT mice. Although consistent with its basal cell expression, the differential expression level of NS in MDA-MB231 versus MCF7 cells may also result from other known differences between these two cell lines, including their hormone status and genetic makeup. Second, we show that the NS level is significantly increased from the P0 to P1 sphere culture, which parallels the increase of sphere-forming activity from P0 to P1. Most importantly, NS-enriched tumor cells display stronger tumorigenic capacities in vitro and contain more TIC in vivo compared with NS-deficient mammary tumor cells. TIC is 80-fold enriched in the NS hi population compared with the NS lo population. This enrichment scale is better than the combinatorial use of several markers to enrich for TIC in mouse models of breast cancer. For TIC frequency of NS hi cells is only 1 in 6,006, which may be due to the physical damage to the cells during the FACS procedure and the cellular heterogeneity of the NS hi group, as seen with other sorting paradigms as well. GFP NS mammary tumors clearly contain two distinct populations, i.e., the GFP + and GFP − cells. According to their marker expression profiles (Fig. 5C ), these two groups may represent the epithelial and nonepithelial components of the tumors, respectively. Within the GFP + group, signals are distributed in continuum, indicating that the differences in NS expression between different subsets of epithelial tumor cells are relative rather than absolute and that the TIC frequency of NS hi cells may be further improved by a higher gating threshold. However, once formed, the transplanted tumors derived from the NS hi cells display the same growth rate as those derived from the NS med and NS lo cells. A direct involvement of NS in mammary tumor progression is shown by the knockdown experiments, which show that NS depletion significantly reduces the sphere-forming activity of human breast cancer cells. Based on these findings, we conclude that NS and NS-enriched mammary tumor cells are functionally involved in mammary tumor progression and possibly recurrence.
Molecular identity of NS-enriched mammary tumor cells
To elucidate the molecular property of NS-enriched mammary tumor cells and to gain insight on the pathways coregulated with NS, we analyzed the expression profiles of the four GFP-sorted tumor cells and showed that the NS expression correlates significantly with the expressions of K5, CXCL12, CD133, Oct4, and TERT (P < 0.05). Because the probability of two different cell types cosegregrating in all four GFP-sorted groups is low, we conclude that tumor cells expressing more NS also express more K5, CXCL12, CD133, Oct4, and TERT. The CXCL12 cytokine is the ligand for CXCR4 that plays a role in mediating the in vitro invasive property and in vivo metastatic property of mammary tumors. TERT mediates telomere lengthening and is highly expressed by the majority of human cancer cells to maintain their telomere integrity. CD133 and Oct4 are neural stem cell and ES markers that have been used to enrich for mCSC as well (19, 20) . It should be noted that in normal mammary glands, the expressions of CD133, Sca-1, and Bmi-1 are not restricted to the stem cell compartment. CD133 and Sca-1 are also expressed by the ER + luminal cells in normal mammary glands (44, 45) . On the other hand, although Bmi-1 promotes stem and progenitor cell expansion, it is commonly expressed in all mammary cells (46, 47) . These differences may highlight the molecular distinction between mCSCs and normal mammary stem cells.
In conclusion, NS is preferentially expressed by the basal subtype of mammary tumor cells and mCSC. NS-enriched mammary tumor cells express more CSC-related genes and show higher tumorigenic activities compared with NSdeficient tumor cells. In addition, NS is required for the sphere-forming activity of human breast cancer cells. Therefore, NS may be a potential target for CSC-based breast cancer treatment.
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